Knee Cartilage Lesions

3

Review clinical trials related to Knee Cartilage Lesions. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Effect of Lipedema on Knee Osteoarthritis

This study will be one of the few to examine the effect of lipedema on knee osteoarthritis in a comparative manner with a control group within the same osteoarthritis context. Although the relationship between obesity and osteoarthritis has been extensively studied in the literature, the effect of specific adipose tissue pathologies, such as lipedema, on osteoarthritis has not been sufficiently investigated. This study aims to demonstrate the independent effect of lipedema on osteoarthritis, evaluate clinical and ultrasonographic parameters together, and contribute to early diagnosis and targeted rehabilitation strategies.

Participants needed: 76
Trial details
Age: 30-65Biological sex: FemaleType: ObservationalSponsor: Izmir Democracy UniversityUpdated: May 8, 2026Locations: 1Duration: 1 Day
Eligibility criteria

Women aged 30-65 [+6]

Inflammatory arthritis [+10]

Status: Recruiting

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Participants needed: 10
Trial details
Age: 22-60Biological sex: AllType: InterventionalSponsor: Nanochon, Inc.Updated: Apr 22, 2026Locations: 2
Eligibility criteria

Male or female ≥22 years and ≤ 60 years of age [+3]

Any known systemic cartilage and/or bone disorder, such as, but not limited to,... [+15]

Status: Not yet recruiting

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Participants needed: 5
Trial details
Age: 22-60Biological sex: AllType: InterventionalSponsor: Nanochon, Inc.Updated: Apr 21, 2026Locations: 1
Eligibility criteria

Male or female ≥22 years and ≤ 60 years of age [+3]

Any known systemic cartilage and/or bone disorder, such as, but not limited to,... [+15]